Cancer immunotherapy by NC410, a LAIR-2 Fc protein blocking human LAIR-collagen interaction
Collagens are a primary component of the extracellular matrix and are functional ligands for the inhibitory immune receptor leukocyte-associated immunoglobulin-like receptor (LAIR)-1. LAIR-2 is a secreted protein that can act as a decoy receptor by binding collagen with higher affinity than LAIR-1....
Saved in:
Published in | eLife Vol. 10 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Cambridge
eLife Science Publications, Ltd
14.06.2021
eLife Sciences Publications Ltd eLife Sciences Publications, Ltd |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Collagens are a primary component of the extracellular matrix and are functional ligands for the inhibitory immune receptor leukocyte-associated immunoglobulin-like receptor (LAIR)-1. LAIR-2 is a secreted protein that can act as a decoy receptor by binding collagen with higher affinity than LAIR-1. We propose that collagens promote immune evasion by interacting with LAIR-1 expressed on immune cells, and that LAIR-2 releases LAIR-1-mediated immune suppression. Analysis of public human datasets shows that collagens, LAIR-1 and LAIR-2 have unique and overlapping associations with survival in certain tumors. We designed a dimeric LAIR-2 with a functional IgG1 Fc tail, NC410, and showed that NC410 increases human T cell expansion and effector function in vivo in a mouse xenogeneic-graft versus-host disease model. In humanized mouse tumor models, NC410 reduces tumor growth that is dependent on T cells. Immunohistochemical analysis of human tumors shows that NC410 binds to collagen-rich areas where LAIR-1
+
immune cells are localized. Our findings show that NC410 might be a novel strategy for cancer immunotherapy for immune-excluded tumors. |
---|---|
AbstractList | Collagens are a primary component of the extracellular matrix and are functional ligands for the inhibitory immune receptor leukocyte-associated immunoglobulin-like receptor (LAIR)-1. LAIR-2 is a secreted protein that can act as a decoy receptor by binding collagen with higher affinity than LAIR-1. We propose that collagens promote immune evasion by interacting with LAIR-1 expressed on immune cells, and that LAIR-2 releases LAIR-1-mediated immune suppression. Analysis of public human datasets shows that collagens, LAIR-1 and LAIR-2 have unique and overlapping associations with survival in certain tumors. We designed a dimeric LAIR-2 with a functional IgG1 Fc tail, NC410, and showed that NC410 increases human T cell expansion and effector function in vivo in a mouse xenogeneic-graft versus-host disease model. In humanized mouse tumor models, NC410 reduces tumor growth that is dependent on T cells. Immunohistochemical analysis of human tumors shows that NC410 binds to collagen-rich areas where LAIR-1+ immune cells are localized. Our findings show that NC410 might be a novel strategy for cancer immunotherapy for immune-excluded tumors. Collagens are a primary component of the extracellular matrix and are functional ligands for the inhibitory immune receptor leukocyte-associated immunoglobulin-like receptor (LAIR)-1. LAIR-2 is a secreted protein that can act as a decoy receptor by binding collagen with higher affinity than LAIR-1. We propose that collagens promote immune evasion by interacting with LAIR-1 expressed on immune cells, and that LAIR-2 releases LAIR-1-mediated immune suppression. Analysis of public human datasets shows that collagens, LAIR-1 and LAIR-2 have unique and overlapping associations with survival in certain tumors. We designed a dimeric LAIR-2 with a functional IgG1 Fc tail, NC410, and showed that NC410 increases human T cell expansion and effector function in vivo in a mouse xenogeneic-graft versus-host disease model. In humanized mouse tumor models, NC410 reduces tumor growth that is dependent on T cells. Immunohistochemical analysis of human tumors shows that NC410 binds to collagen-rich areas where LAIR-1 + immune cells are localized. Our findings show that NC410 might be a novel strategy for cancer immunotherapy for immune-excluded tumors. Collagens are a primary component of the extracellular matrix and are functional ligands for the inhibitory immune receptor leukocyte-associated immunoglobulin-like receptor (LAIR)-1. LAIR-2 is a secreted protein that can act as a decoy receptor by binding collagen with higher affinity than LAIR-1. We propose that collagens promote immune evasion by interacting with LAIR-1 expressed on immune cells, and that LAIR-2 releases LAIR-1-mediated immune suppression. Analysis of public human datasets shows that collagens, LAIR-1 and LAIR-2 have unique and overlapping associations with survival in certain tumors. We designed a dimeric LAIR-2 with a functional IgG1 Fc tail, NC410, and showed that NC410 increases human T cell expansion and effector function in vivo in a mouse xenogeneic-graft versus-host disease model. In humanized mouse tumor models, NC410 reduces tumor growth that is dependent on T cells. Immunohistochemical analysis of human tumors shows that NC410 binds to collagen-rich areas where LAIR-1.sup.+ immune cells are localized. Our findings show that NC410 might be a novel strategy for cancer immunotherapy for immune-excluded tumors. |
Audience | Academic |
Author | Song, Chang Paucarmayta, Ana Bosiacki, Jason Singh, Akashdip Willumsen, Nicholas de Ruiter, Emma J Flies, Dallas Vijver, Saskia V Tian, Linjie Willems, Stefan Liu, Linda Karsdal, Morten A Shaik, Jahangheer Jensen, Christina Elshof, Eline Cusumano, Zachary Langermann, Sol Ramos, M Ines Pascoal Meyaard, Linde |
Author_xml | – sequence: 1 fullname: Ramos, M Ines Pascoal – sequence: 2 fullname: Tian, Linjie – sequence: 3 fullname: de Ruiter, Emma J – sequence: 4 fullname: Song, Chang – sequence: 5 fullname: Paucarmayta, Ana – sequence: 6 fullname: Singh, Akashdip – sequence: 7 fullname: Elshof, Eline – sequence: 8 fullname: Vijver, Saskia V – sequence: 9 fullname: Shaik, Jahangheer – sequence: 10 fullname: Bosiacki, Jason – sequence: 11 fullname: Cusumano, Zachary – sequence: 12 fullname: Jensen, Christina – sequence: 13 fullname: Willumsen, Nicholas – sequence: 14 fullname: Karsdal, Morten A – sequence: 15 fullname: Liu, Linda – sequence: 16 fullname: Langermann, Sol – sequence: 17 fullname: Willems, Stefan – sequence: 18 fullname: Flies, Dallas – sequence: 19 fullname: Meyaard, Linde |
BookMark | eNptklGL1DAQgIuceOd5T_6Bgi-K7pqkSZq-HCyLpwuLwqkg-BCm6aSbtU3WtBX335vbPdQVk4eEyTdfyGQeZ2c-eMyyp5TMSyH4a1w7i3PJKlY-yC4YEWRGFP9y9tf-PLsahi1Jo-RK0epRdl5wyqgU6iL7ugRvMOau7ycfxg1G2O3zep-_X3JKXuWQrxer2xnLb0y-i2FE5_O6C-ab822-mXrwR8CEroMWfe78mBxmdME_yR5a6Aa8ul8vs883bz4t383WH96ulov1zAhRjLOScVoZpbARteVGVZQyoqgtLcGmIigVIVQZNKLmhtYA0lhJWMNLiTUURXGZrY7eJsBW76LrIe51AKcPgRBbDXF0pkNtKgNAoYCmarg0HIAzy21BoFZAZJ1c10fXbqp7bAz6MUJ3Ij098W6j2_BDK8ZEoaokeH4viOH7hMOoezcYTNXxGKZBM8FJyQShJKHP_kG3YYo-lSpRlUgfWJbqD9VCeoDzNqR7zZ1UL6SUBSOc8ETN_0Ol2WDvTOoZ61L8JOHFSUJiRvw5tjANg159vD1lXx5ZE8MwRLS_60GJvmtDfWhDfWjD4hfNc8zu |
CitedBy_id | crossref_primary_10_1016_j_biopha_2023_115390 crossref_primary_10_1016_j_clinbiochem_2021_08_007 crossref_primary_10_1016_j_tips_2024_04_006 crossref_primary_10_1158_2326_6066_CIR_23_0496 crossref_primary_10_1042_BST20221083 crossref_primary_10_1093_cei_uxad073 crossref_primary_10_3389_fimmu_2024_1360291 crossref_primary_10_3389_fimmu_2021_733561 crossref_primary_10_1038_s12276_022_00774_4 crossref_primary_10_1146_annurev_immunol_101721_065214 crossref_primary_10_18632_aging_204631 crossref_primary_10_3389_fimmu_2021_791453 crossref_primary_10_1016_j_iotech_2023_100383 crossref_primary_10_1126_scitranslmed_abo3605 crossref_primary_10_1186_s12943_023_01744_8 crossref_primary_10_3390_cancers15174323 crossref_primary_10_1016_j_coi_2022_102246 crossref_primary_10_1186_s12916_023_03137_6 crossref_primary_10_1038_s41467_023_36691_x crossref_primary_10_3389_fimmu_2023_1199513 crossref_primary_10_1186_s13046_021_02133_z crossref_primary_10_3390_diagnostics12102497 crossref_primary_10_1007_s00262_023_03600_6 crossref_primary_10_3389_fimmu_2022_996026 crossref_primary_10_1007_s13402_023_00830_9 crossref_primary_10_1172_JCI169519 crossref_primary_10_1080_15384047_2024_2308097 crossref_primary_10_3724_abbs_2024107 crossref_primary_10_1016_j_trecan_2023_06_002 crossref_primary_10_1158_2767_9764_CRC_22_0334 crossref_primary_10_3390_ijms232416136 crossref_primary_10_1016_j_tcb_2023_08_003 crossref_primary_10_1016_j_addr_2023_114771 crossref_primary_10_1371_journal_pone_0287733 crossref_primary_10_1016_j_bbrc_2022_09_019 crossref_primary_10_1186_s12967_024_05199_3 crossref_primary_10_1172_JCI155148 crossref_primary_10_1016_j_cellsig_2024_111039 crossref_primary_10_1186_s13046_023_02942_4 |
Cites_doi | 10.1073/pnas.1212753109 10.2119/molmed.2014.00185 10.1186/1471-2105-14-S9-S1 10.1016/j.immuni.2014.11.012 10.1002/(SICI)1521-4141(199910)29:10<3160::AID-IMMU3160>3.0.CO;2-S 10.1158/1078-0432.CCR-13-2972 10.1128/CDLI.12.6.705-712.2005 10.1126/science.1176009 10.1016/j.cellimm.2013.12.005 10.1155/2000/43657 10.1083/jcb.201102147 10.1002/(SICI)1521-4141(199807)28:07<2086::AID-IMMU2086>3.0.CO;2-T 10.1038/onc.2013.307 10.1016/j.cell.2009.10.027 10.1038/nrc.2016.73 10.1158/1078-0432.CCR-13-1256 10.1016/j.devcel.2015.07.005 10.21315/mjms2017.24.5.11 10.1371/journal.pone.0063282 10.1038/86286 10.1038/s12276-018-0191-1 10.1080/2162402X.2020.1740477 10.3390/cancers12102786 10.1002/art.30612 10.1158/1078-0432.CCR-14-1860 10.15252/embj.201490147 10.1038/ncomms10346 10.1371/journal.pone.0044219 10.1038/s41591-018-0136-1 10.1038/nrm3904 10.1186/s40425-018-0474-z 10.1189/jlb.3AB0213-092RR 10.7554/eLife.01308 10.1172/JCI45817 10.1016/S1470-2045(16)30406-5 10.1016/j.molimm.2011.09.006 10.1158/1078-0432.CCR-13-1059 10.3389/fimmu.2018.01943 10.18632/oncotarget.2421 10.1186/s40425-019-0556-6 10.1038/s41591-018-0014-x 10.1107/S0907444908007877 10.1155/2014/365867 10.1038/s41467-020-18298-8 10.1186/s13046-019-1110-6 10.1074/jbc.RA119.011150 10.1186/s12967-019-2058-1 10.1007/s13277-013-1511-7 10.1016/s1074-7613(00)80530-0 10.1186/1471-2407-14-518 10.1016/j.immuni.2013.07.012 10.15252/embr.201439246 10.1158/1078-0432.CCR-04-0443 10.1016/j.tig.2003.11.004 10.1084/jem.20052554 10.1186/s12931-020-01369-1 10.3389/fimmu.2020.02156 10.3389/fmolb.2019.00160 10.4049/jimmunol.180.3.1662 10.1101/cshperspect.a028472 10.1186/s12967-021-02701-z 10.1016/j.molimm.2005.01.004 10.1074/mcp.M111.014647 10.4103/0976-500X.119726 10.1038/nature21349 10.2147/OTT.S160196 10.1159/000354976 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2021 eLife Science Publications, Ltd. 2021, Ramos et al. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2021, Ramos et al 2021 Ramos et al |
Copyright_xml | – notice: COPYRIGHT 2021 eLife Science Publications, Ltd. – notice: 2021, Ramos et al. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2021, Ramos et al 2021 Ramos et al |
DBID | AAYXX CITATION ISR 3V. 7X7 7XB 88E 88I 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2P M7P PIMPY PQEST PQQKQ PQUKI PRINS Q9U 7X8 5PM DOA |
DOI | 10.7554/eLife.62927 |
DatabaseName | CrossRef Gale In Context: Science ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials Biological Science Collection AUTh Library subscriptions: ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Science Database (ProQuest) Biological Science Database Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) Open Access: DOAJ - Directory of Open Access Journals |
DatabaseTitle | CrossRef Publicly Available Content Database ProQuest Central Student ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database CrossRef |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: BENPR name: AUTh Library subscriptions: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 2050-084X |
ExternalDocumentID | oai_doaj_org_article_c9caa1a3ad9d46c4aa42f4f30ab8a06b A666320404 10_7554_eLife_62927 |
GeographicLocations | Morocco |
GeographicLocations_xml | – name: Morocco |
GrantInformation_xml | – fundername: ; grantid: Vici 918.15.608 |
GroupedDBID | 3V. 53G 5VS 7X7 88E 88I 8FE 8FH 8FI 8FJ AAFWJ AAKDD AAYXX ABUWG ACGFO ACGOD ACPRK ADBBV ADRAZ AENEX AFKRA AFPKN ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI CCPQU CITATION DIK DWQXO EMOBN FRP FYUFA GNUQQ GROUPED_DOAJ GX1 HCIFZ HMCUK HYE IAO IEA IHR INH INR ISR ITC KQ8 LK8 M1P M2P M48 M7P M~E NQS OK1 PGMZT PIMPY PQQKQ PROAC PSQYO RHF RHI RNS RPM UKHRP 7XB 8FK K9. PQEST PQUKI PRINS Q9U 7X8 5PM |
ID | FETCH-LOGICAL-c553t-72419c88ed5bf4c89112081f7f0ed90e680018cec5b4c1baa6cf602d476eba333 |
IEDL.DBID | RPM |
ISSN | 2050-084X |
IngestDate | Tue Oct 22 15:09:42 EDT 2024 Tue Sep 17 21:25:37 EDT 2024 Thu Oct 24 23:31:22 EDT 2024 Thu Oct 10 17:39:23 EDT 2024 Thu Feb 22 23:44:14 EST 2024 Fri Feb 02 04:15:09 EST 2024 Thu Aug 01 19:46:56 EDT 2024 Fri Aug 23 00:57:26 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Language | English |
License | This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c553t-72419c88ed5bf4c89112081f7f0ed90e680018cec5b4c1baa6cf602d476eba333 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Department of Pathology and Medical Biology, University Medical Center Groningen, Groningen, The Netherlands. These authors contributed equally to this work. These authors also contributed equally to this work. |
ORCID | 0000-0003-3644-6517 0000-0003-0707-4793 0000-0001-5326-8826 0000-0002-9280-2080 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225389/ |
PMID | 34121658 |
PQID | 2595205778 |
PQPubID | 2045579 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_c9caa1a3ad9d46c4aa42f4f30ab8a06b pubmedcentral_primary_oai_pubmedcentral_nih_gov_8225389 proquest_miscellaneous_2540725010 proquest_journals_2595205778 gale_infotracmisc_A666320404 gale_infotracacademiconefile_A666320404 gale_incontextgauss_ISR_A666320404 crossref_primary_10_7554_eLife_62927 |
PublicationCentury | 2000 |
PublicationDate | 2021-06-14 |
PublicationDateYYYYMMDD | 2021-06-14 |
PublicationDate_xml | – month: 06 year: 2021 text: 2021-06-14 day: 14 |
PublicationDecade | 2020 |
PublicationPlace | Cambridge |
PublicationPlace_xml | – name: Cambridge |
PublicationTitle | eLife |
PublicationYear | 2021 |
Publisher | eLife Science Publications, Ltd eLife Sciences Publications Ltd eLife Sciences Publications, Ltd |
Publisher_xml | – name: eLife Science Publications, Ltd – name: eLife Sciences Publications Ltd – name: eLife Sciences Publications, Ltd |
References | Olde Nordkamp (bib44) 2014; 96 Naba (bib39) 2014; 14 Rosowski (bib51) 2015; 34 Beatty (bib4) 2015; 21 Strieter (bib59) 2001; 2 Zhang (bib67) 2014; 287 Park (bib45) 2020; 295 Oganesyan (bib41) 2008; 64 Olde Nordkamp (bib42) 2011; 63 St-Pierre (bib58) 2000; 7 Kuczek (bib28) 2019; 7 Xu (bib65) 2019; 17 Rygiel (bib52) 2011; 49 Bulla (bib7) 2016; 7 Xu (bib66) 2020; 9 Arifin (bib3) 2017; 24 Olde Nordkamp (bib43) 2014; 6 Son (bib57) 2015; 20 Simone (bib54) 2013; 8 Waldmann (bib61) 2018; 10 Henke (bib18) 2019; 6 Wang (bib62) 2021; 19 Fang (bib15) 2014; 35 Binnewies (bib5) 2018; 24 Myllyharju (bib36) 2004; 20 Ke (bib27) 2014; 5 Januchowski (bib22) 2014; 2014 Ali (bib1) 2012; 7 Wu (bib63) 2014; 33 Nissen (bib40) 2019; 38 Chen (bib9) 2013; 39 Lebbink (bib29) 2006; 203 Jensen (bib24) 2020; 12 Xu (bib64) 2013; 14 Suppl 9 Prakash (bib49) 2014; 41 Cheon (bib11) 2014; 20 Levental (bib31) 2009; 139 Hartmann (bib17) 2014; 20 Gibney (bib16) 2016; 17 Peng (bib46) 2020; 11 Son (bib56) 2012; 109 Maasho (bib33) 2005; 42 Bonnans (bib6) 2014; 15 Poggi (bib48) 1998; 28 Cox (bib12) 2014; 20 Huang (bib19) 2018; 11 Lu (bib32) 2012; 196 Lebbink (bib30) 2008; 180 Merlo (bib34) 2005; 12 van der Vuurst de Vries (bib60) 1999; 29 Iizasa (bib21) 2004; 10 Ehx (bib14) 2018; 9 Charan (bib8) 2013; 4 Antonio (bib2) 2015; 34 Naba (bib37) 2012; 11 Jiang (bib25) 2018; 24 Salmon (bib53) 2012; 122 Rønnow (bib50) 2020; 21 Darvin (bib13) 2018; 50 Jensen (bib23) 2018; 6 Naba (bib38) 2014; 3 Chen (bib10) 2017; 541 Kalluri (bib26) 2016; 16 Meyaard (bib35) 1997; 7 Sivori (bib55) 2020; 11 Pickup (bib47) 2014; 15 Hynes (bib20) 2009; 326 |
References_xml | – volume: 109 start-page: E3160 year: 2012 ident: bib56 article-title: C1q limits dendritic cell differentiation and activation by engaging LAIR-1 publication-title: PNAS doi: 10.1073/pnas.1212753109 contributor: fullname: Son – volume: 20 start-page: 559 year: 2015 ident: bib57 article-title: C1q-mediated repression of human monocytes is regulated by leukocyte-associated Ig-like receptor 1 (LAIR-1) publication-title: Molecular Medicine doi: 10.2119/molmed.2014.00185 contributor: fullname: Son – volume: 14 Suppl 9 year: 2013 ident: bib64 article-title: Parallel comparison of Illumina RNA-Seq and Affymetrix microarray platforms on transcriptomic profiles generated from 5-aza-deoxy-cytidine treated HT-29 colon cancer cells and simulated datasets publication-title: BMC Bioinformatics doi: 10.1186/1471-2105-14-S9-S1 contributor: fullname: Xu – volume: 41 start-page: 960 year: 2014 ident: bib49 article-title: Granzyme B promotes cytotoxic lymphocyte transmigration via basement membrane remodeling publication-title: Immunity doi: 10.1016/j.immuni.2014.11.012 contributor: fullname: Prakash – volume: 29 start-page: 3160 year: 1999 ident: bib60 article-title: Leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1) is differentially expressed during human B cell differentiation and inhibits B cell receptor-mediated signaling publication-title: European Journal of Immunology doi: 10.1002/(SICI)1521-4141(199910)29:10<3160::AID-IMMU3160>3.0.CO;2-S contributor: fullname: van der Vuurst de Vries – volume: 20 start-page: 3422 year: 2014 ident: bib17 article-title: Prevailing role of contact guidance in intrastromal T-cell trapping in human pancreatic cancer publication-title: Clinical Cancer Research doi: 10.1158/1078-0432.CCR-13-2972 contributor: fullname: Hartmann – volume: 12 start-page: 705 year: 2005 ident: bib34 article-title: Inhibitory receptors CD85j, LAIR-1, and CD152 down-regulate immunoglobulin and cytokine production by human B lymphocytes publication-title: Clinical and Diagnostic Laboratory Immunology doi: 10.1128/CDLI.12.6.705-712.2005 contributor: fullname: Merlo – volume: 326 start-page: 1216 year: 2009 ident: bib20 article-title: The extracellular matrix: not just pretty fibrils publication-title: Science doi: 10.1126/science.1176009 contributor: fullname: Hynes – volume: 287 start-page: 46 year: 2014 ident: bib67 article-title: The role of LAIR-1 (CD305) in T cells and monocytes/macrophages in patients with rheumatoid arthritis publication-title: Cellular Immunology doi: 10.1016/j.cellimm.2013.12.005 contributor: fullname: Zhang – volume: 7 start-page: 171 year: 2000 ident: bib58 article-title: T cell control of extracellular matrix degradation publication-title: Developmental Immunology doi: 10.1155/2000/43657 contributor: fullname: St-Pierre – volume: 196 start-page: 395 year: 2012 ident: bib32 article-title: The extracellular matrix: a dynamic niche in Cancer progression publication-title: The Journal of Cell Biology doi: 10.1083/jcb.201102147 contributor: fullname: Lu – volume: 28 start-page: 2086 year: 1998 ident: bib48 article-title: p40/LAIR-1 regulates the differentiation of peripheral blood precursors to dendritic cells induced by granulocyte-monocyte colony-stimulating factor publication-title: European Journal of Immunology doi: 10.1002/(SICI)1521-4141(199807)28:07<2086::AID-IMMU2086>3.0.CO;2-T contributor: fullname: Poggi – volume: 33 start-page: 3432 year: 2014 ident: bib63 article-title: COL11A1 promotes tumor progression and predicts poor clinical outcome in ovarian cancer publication-title: Oncogene doi: 10.1038/onc.2013.307 contributor: fullname: Wu – volume: 139 start-page: 891 year: 2009 ident: bib31 article-title: Matrix crosslinking forces tumor progression by enhancing integrin signaling publication-title: Cell doi: 10.1016/j.cell.2009.10.027 contributor: fullname: Levental – volume: 16 start-page: 582 year: 2016 ident: bib26 article-title: The biology and function of fibroblasts in cancer publication-title: Nature Reviews. Cancer doi: 10.1038/nrc.2016.73 contributor: fullname: Kalluri – volume: 20 start-page: 711 year: 2014 ident: bib11 article-title: A collagen-remodeling gene signature regulated by TGF-β signaling is associated with metastasis and poor survival in serous ovarian cancer publication-title: Clinical Cancer Research doi: 10.1158/1078-0432.CCR-13-1256 contributor: fullname: Cheon – volume: 34 start-page: 134 year: 2015 ident: bib51 article-title: Neutrophils, wounds, and cancer progression publication-title: Developmental Cell doi: 10.1016/j.devcel.2015.07.005 contributor: fullname: Rosowski – volume: 24 start-page: 101 year: 2017 ident: bib3 article-title: Sample Size Calculation in Animal Studies Using Resource Equation Approach publication-title: The Malaysian Journal of Medical Sciences : MJMS doi: 10.21315/mjms2017.24.5.11 contributor: fullname: Arifin – volume: 8 year: 2013 ident: bib54 article-title: Serum LAIR-2 is increased in autoimmune thyroid diseases publication-title: PLOS ONE doi: 10.1371/journal.pone.0063282 contributor: fullname: Simone – volume: 2 start-page: 285 year: 2001 ident: bib59 article-title: Chemokines: not just leukocyte chemoattractants in the promotion of cancer publication-title: Nature Immunology doi: 10.1038/86286 contributor: fullname: Strieter – volume: 50 start-page: 1 year: 2018 ident: bib13 article-title: Immune checkpoint inhibitors: recent progress and potential biomarkers publication-title: Experimental & Molecular Medicine doi: 10.1038/s12276-018-0191-1 contributor: fullname: Darvin – volume: 9 year: 2020 ident: bib66 article-title: Cancer immunotherapy based on blocking immune suppression mediated by an immune modulator LAIR-1 publication-title: Oncoimmunology doi: 10.1080/2162402X.2020.1740477 contributor: fullname: Xu – volume: 12 year: 2020 ident: bib24 article-title: Granzyme B degraded type IV collagen products in serum identify melanoma patients responding to immune checkpoint blockade publication-title: Cancers doi: 10.3390/cancers12102786 contributor: fullname: Jensen – volume: 63 start-page: 3749 year: 2011 ident: bib42 article-title: Enhanced secretion of leukocyte-associated immunoglobulin-like receptor 2 (LAIR-2) and soluble LAIR-1 in rheumatoid arthritis: LAIR-2 is a more efficient antagonist of the LAIR-1-collagen inhibitory interaction than is soluble LAIR-1 publication-title: Arthritis and Rheumatism doi: 10.1002/art.30612 contributor: fullname: Olde Nordkamp – volume: 21 start-page: 687 year: 2015 ident: bib4 article-title: Immune escape mechanisms as a guide for cancer immunotherapy publication-title: Clinical Cancer Research doi: 10.1158/1078-0432.CCR-14-1860 contributor: fullname: Beatty – volume: 34 start-page: 2219 year: 2015 ident: bib2 article-title: The wound inflammatory response exacerbates growth of pre-neoplastic cells and progression to cancer publication-title: The EMBO Journal doi: 10.15252/embj.201490147 contributor: fullname: Antonio – volume: 7 year: 2016 ident: bib7 article-title: C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation publication-title: Nature Communications doi: 10.1038/ncomms10346 contributor: fullname: Bulla – volume: 7 year: 2012 ident: bib1 article-title: Xenogeneic graft-versus-host-disease in NOD-scid IL-2Rγnull mice display a T-effector memory phenotype publication-title: PLOS ONE doi: 10.1371/journal.pone.0044219 contributor: fullname: Ali – volume: 24 start-page: 1550 year: 2018 ident: bib25 article-title: Signatures of T cell dysfunction and exclusion predict Cancer immunotherapy response publication-title: Nature Medicine doi: 10.1038/s41591-018-0136-1 contributor: fullname: Jiang – volume: 15 start-page: 786 year: 2014 ident: bib6 article-title: Remodelling the extracellular matrix in development and disease publication-title: Nature Reviews. Molecular Cell Biology doi: 10.1038/nrm3904 contributor: fullname: Bonnans – volume: 6 year: 2018 ident: bib23 article-title: Non-invasive biomarkers derived from the extracellular matrix associate with response to immune checkpoint blockade (anti-CTLA-4) in metastatic melanoma patients publication-title: Journal for Immunotherapy of Cancer doi: 10.1186/s40425-018-0474-z contributor: fullname: Jensen – volume: 96 start-page: 105 year: 2014 ident: bib44 article-title: Leukocyte-associated Ig-like receptor-1 is a novel inhibitory receptor for surfactant protein D publication-title: Journal of Leukocyte Biology doi: 10.1189/jlb.3AB0213-092RR contributor: fullname: Olde Nordkamp – volume: 3 year: 2014 ident: bib38 article-title: Extracellular matrix signatures of human mammary carcinoma identify novel metastasis promoters publication-title: eLife doi: 10.7554/eLife.01308 contributor: fullname: Naba – volume: 122 start-page: 899 year: 2012 ident: bib53 article-title: Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors publication-title: Journal of Clinical Investigation doi: 10.1172/JCI45817 contributor: fullname: Salmon – volume: 17 start-page: E542 year: 2016 ident: bib16 article-title: Predictive biomarkers for checkpoint inhibitor-based immunotherapy publication-title: The Lancet. Oncology doi: 10.1016/S1470-2045(16)30406-5 contributor: fullname: Gibney – volume: 49 start-page: 402 year: 2011 ident: bib52 article-title: Tumor-expressed collagens can modulate immune cell function through the inhibitory collagen receptor LAIR-1 publication-title: Molecular Immunology doi: 10.1016/j.molimm.2011.09.006 contributor: fullname: Rygiel – volume: 20 start-page: 3637 year: 2014 ident: bib12 article-title: Molecular pathways: connecting fibrosis and solid tumor metastasis publication-title: Clinical Cancer Research doi: 10.1158/1078-0432.CCR-13-1059 contributor: fullname: Cox – volume: 9 year: 2018 ident: bib14 article-title: Xenogeneic Graft-Versus-Host Disease in Humanized NSG and NSG-HLA-A2/HHD Mice publication-title: Frontiers in Immunology doi: 10.3389/fimmu.2018.01943 contributor: fullname: Ehx – volume: 5 start-page: 9410 year: 2014 ident: bib27 article-title: Overexpression of collagen triple helix repeat containing 1 (CTHRC1) is associated with tumour aggressiveness and poor prognosis in human non-small cell lung cancer publication-title: Oncotarget doi: 10.18632/oncotarget.2421 contributor: fullname: Ke – volume: 7 year: 2019 ident: bib28 article-title: Collagen density regulates the activity of tumor-infiltrating T cells publication-title: Journal for Immunotherapy of Cancer doi: 10.1186/s40425-019-0556-6 contributor: fullname: Kuczek – volume: 24 start-page: 541 year: 2018 ident: bib5 article-title: Understanding the tumor immune microenvironment (TIME) for effective therapy publication-title: Nature Medicine doi: 10.1038/s41591-018-0014-x contributor: fullname: Binnewies – volume: 64 start-page: 700 year: 2008 ident: bib41 article-title: Structural characterization of a human Fc fragment engineered for lack of effector functions publication-title: Acta Crystallographica. Section D, Biological Crystallography doi: 10.1107/S0907444908007877 contributor: fullname: Oganesyan – volume: 2014 year: 2014 ident: bib22 article-title: Extracellular matrix proteins expression profiling in chemoresistant variants of the A2780 ovarian Cancer cell line publication-title: BioMed Research International doi: 10.1155/2014/365867 contributor: fullname: Januchowski – volume: 11 year: 2020 ident: bib46 article-title: Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8+ T cell exhaustion publication-title: Nature Communications doi: 10.1038/s41467-020-18298-8 contributor: fullname: Peng – volume: 38 year: 2019 ident: bib40 article-title: Collagens and Cancer associated fibroblasts in the reactive stroma and its relation to Cancer biology publication-title: Journal of Experimental & Clinical Cancer Research doi: 10.1186/s13046-019-1110-6 contributor: fullname: Nissen – volume: 295 start-page: 2239 year: 2020 ident: bib45 article-title: Leukocyte-associated immunoglobulin-like receptor 1 inhibits T-cell signaling by decreasing protein phosphorylation in the T-cell signaling pathway publication-title: Journal of Biological Chemistry doi: 10.1074/jbc.RA119.011150 contributor: fullname: Park – volume: 17 year: 2019 ident: bib65 article-title: The role of collagen in cancer: from bench to bedside publication-title: Journal of Translational Medicine doi: 10.1186/s12967-019-2058-1 contributor: fullname: Xu – volume: 35 start-page: 2871 year: 2014 ident: bib15 article-title: Collagen as a double-edged sword in tumor progression publication-title: Tumour Biology : The Journal of the International Society for Oncodevelopmental Biology and Medicine doi: 10.1007/s13277-013-1511-7 contributor: fullname: Fang – volume: 7 start-page: 283 year: 1997 ident: bib35 article-title: LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes publication-title: Immunity doi: 10.1016/s1074-7613(00)80530-0 contributor: fullname: Meyaard – volume: 14 year: 2014 ident: bib39 article-title: Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver publication-title: BMC Cancer doi: 10.1186/1471-2407-14-518 contributor: fullname: Naba – volume: 39 start-page: 1 year: 2013 ident: bib9 article-title: Oncology meets immunology: the cancer-immunity cycle publication-title: Immunity doi: 10.1016/j.immuni.2013.07.012 contributor: fullname: Chen – volume: 15 start-page: 1243 year: 2014 ident: bib47 article-title: The extracellular matrix modulates the hallmarks of cancer publication-title: EMBO Reports doi: 10.15252/embr.201439246 contributor: fullname: Pickup – volume: 10 start-page: 5361 year: 2004 ident: bib21 article-title: Overexpression of collagen XVIII is associated with poor outcome and elevated levels of circulating serum endostatin in non-small cell lung cancer publication-title: Clinical Cancer Research doi: 10.1158/1078-0432.CCR-04-0443 contributor: fullname: Iizasa – volume: 20 start-page: 33 year: 2004 ident: bib36 article-title: Collagens, modifying enzymes and their mutations in humans, flies and worms publication-title: Trends in Genetics doi: 10.1016/j.tig.2003.11.004 contributor: fullname: Myllyharju – volume: 203 start-page: 1419 year: 2006 ident: bib29 article-title: Collagens are functional, high affinity ligands for the inhibitory immune receptor LAIR-1 publication-title: The Journal of Experimental Medicine doi: 10.1084/jem.20052554 contributor: fullname: Lebbink – volume: 21 year: 2020 ident: bib50 article-title: Prolonged Scar-in-a-Jar: an in vitro screening tool for anti-fibrotic therapies using biomarkers of extracellular matrix synthesis publication-title: Respiratory Research doi: 10.1186/s12931-020-01369-1 contributor: fullname: Rønnow – volume: 11 year: 2020 ident: bib55 article-title: Inhibitory Receptors and Checkpoints in Human NK Cells, Implications for the Immunotherapy of Cancer publication-title: Frontiers in Immunology doi: 10.3389/fimmu.2020.02156 contributor: fullname: Sivori – volume: 6 year: 2019 ident: bib18 article-title: Extracellular matrix in the tumor microenvironment and its impact on Cancer therapy publication-title: Frontiers in Molecular Biosciences doi: 10.3389/fmolb.2019.00160 contributor: fullname: Henke – volume: 180 start-page: 1662 year: 2008 ident: bib30 article-title: The soluble leukocyte-associated Ig-like receptor (LAIR)-2 antagonizes the collagen/LAIR-1 inhibitory immune interaction publication-title: Journal of Immunology doi: 10.4049/jimmunol.180.3.1662 contributor: fullname: Lebbink – volume: 10 year: 2018 ident: bib61 article-title: Cytokines in cancer immunotherapy publication-title: Cold Spring Harbor Perspectives in Biology doi: 10.1101/cshperspect.a028472 contributor: fullname: Waldmann – volume: 19 year: 2021 ident: bib62 article-title: Blood-based extracellular matrix biomarkers as predictors of survival in patients with metastatic pancreatic ductal adenocarcinoma receiving pegvorhyaluronidase alfa publication-title: Journal of Translational Medicine doi: 10.1186/s12967-021-02701-z contributor: fullname: Wang – volume: 42 start-page: 1521 year: 2005 ident: bib33 article-title: The inhibitory leukocyte-associated Ig-like receptor-1 (LAIR-1) is expressed at high levels by human naive T cells and inhibits TCR mediated activation publication-title: Molecular Immunology doi: 10.1016/j.molimm.2005.01.004 contributor: fullname: Maasho – volume: 11 year: 2012 ident: bib37 article-title: The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices publication-title: Molecular & Cellular Proteomics doi: 10.1074/mcp.M111.014647 contributor: fullname: Naba – volume: 4 start-page: 303 year: 2013 ident: bib8 article-title: How to calculate sample size in animal studies? publication-title: Journal of Pharmacology & Pharmacotherapeutics doi: 10.4103/0976-500X.119726 contributor: fullname: Charan – volume: 541 start-page: 321 year: 2017 ident: bib10 article-title: Elements of cancer immunity and the cancer-immune set point publication-title: Nature doi: 10.1038/nature21349 contributor: fullname: Chen – volume: 11 start-page: 1571 year: 2018 ident: bib19 article-title: High expression of COL10A1 is associated with poor prognosis in colorectal cancer publication-title: OncoTargets and Therapy doi: 10.2147/OTT.S160196 contributor: fullname: Huang – volume: 6 start-page: 284 year: 2014 ident: bib43 article-title: Inhibition of the classical and lectin pathway of the complement system by recombinant LAIR-2 publication-title: Journal of Innate Immunity doi: 10.1159/000354976 contributor: fullname: Olde Nordkamp |
SSID | ssj0000748819 |
Score | 2.533154 |
Snippet | Collagens are a primary component of the extracellular matrix and are functional ligands for the inhibitory immune receptor leukocyte-associated... |
SourceID | doaj pubmedcentral proquest gale crossref |
SourceType | Open Website Open Access Repository Aggregation Database |
SubjectTerms | Animal models Cancer Cancer Biology Cancer immunotherapy Care and treatment Cell growth Collagen Drug therapy Esophageal cancer Extracellular matrix Fc receptors Immunoglobulin G Immunotherapy LAIR1 Liver cancer Lymphocytes T Medical prognosis Ovarian cancer Proteins Survival analysis T cells tumor Tumors Xenografts |
SummonAdditionalLinks | – databaseName: Open Access: DOAJ - Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQT1wQCBCBglxUiQuhSfyKj9sVqxaVHgqVKnGwxo4Ne8lW-zj03zPjpNUGDly4xhMpns-eRzTzDWPHtQ-dsEmXylemlNFDCRholLX1gN4YTMg_3L5e6rNr-eVG3eyN-qKasIEeeFDcSbABoAYBne2kDhJANkkmUYFvodI-W9_K7iVT2QYbPJi1HRryDLrMk3ixTPGTbizNj9lzQZmp_297_GeN5J7TWTxlT8Zokc-Gr3zGHsX-OfsxJ6TWfEmtHWMD1R33d_xyLuvqIwd-MTu_Khu-CDzTMCx77tFn0U9xnmfyDQL5COD54UQZsR4aHF6w68Xn7_OzcpyRUAalxLY06IFtaNvYKZ9kaNF2Nejlk0lV7GwVdUtj90IMystQewAdkq6aThqNuAghXrKDftXHV4wLokdsAaW8QdBQ362PqiVq8WSTagt2fK82dztQYThMIUi7LmvXZe0W7JRU-iBC_NX5AaLqRlTdv1At2HsCxBFDRU8lMD9ht9m4829XboYJl2jQ9siCfRiF0goxCjB2FOB2iNRqInk4kcQrFKbL97i78QpvHOaFqsFo1uDGjx6W6U0qS-vjakcyxC-nMKctmJmcl8n2pyv98lem8cbQDL2Nff0_9PWGPW6o2IaGKslDdrBd7-JbjJa2_l2-GL8BUQgVXQ priority: 102 providerName: Directory of Open Access Journals – databaseName: AUTh Library subscriptions: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Nb9QwELXK9sIFgQARKMhUlbgQmjh24pzQdtVVi9oVWqhUiYNlO3a7l6Tsx6H_nhnHuzQg9bqeVZSZ8byxM_OGkKPc2KaofZkKk1Upd0anGhKNNK-NBjTWlQ0Xbpez8uyKf7sW1_HCbRXLKrcxMQTqprN4R34MabpgkFxU8uvd7xSnRuHX1ThC4wnZZ3BSYCOyf3I6-z7f3bIAQErAvL4xrwLoPHYXC---lKzGOTIPoCgw9v8fl_-tlXwAPtPn5FnMGum4N_MLsufal-TXBC22pAts8YiNVPfU3NPZhOfZZ6rpxfh8njI6tTTQMSxaagC78HKchtl8vUBwBfAjitQRy77R4RW5mp7-nJylcVZCaoUo1mkFSFxbKV0jjOdWQgxjgPa-8plr6syVEsfvWWeF4TY3WpfWlxlreFWCfYqieE1Gbde6N4QWSJMoNUiZCozX1I00TkikGPe1FzIhR1u1qbueEkPBUQK1q4J2VdBuQk5QpTsR5LEOP3TLGxW3hbK11TrXhYan8NJyrTnz3BeZNlJnpUnIIRpEIVNFi6UwN3qzWqnzH3M1hoNXwSAG8YR8ikK-AxtZHTsL4HWQ3GogeTCQhK1kh8tbu6u4lVfqr-Ml5ONuGf-J5Wmt6zYogzxzAs62CakG_jJ4_eFKu7gNdN6QogHq1G8ff_g78pRhOQ2OTeIHZLRebtx7yIfW5kN0-j96ywyD priority: 102 providerName: ProQuest – databaseName: Scholars Portal Open Access Journals dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELfGeOEFDQEisE1mmsQLKYk_4uRpKhXVhsYeBpUq8WDZjr1VQimkrUT_e-6cdCKDh73GZ0W-D9-ddfc7Qk5z62pehSKVNlOp8NakBgKNNK-sAW9slIsPbl-uivOZ-DyX8z2yG8bZM3D139QO50nN2h-j37-2Z2DwEL-OFHjDD_5yEfyoYBVTj8hjhohcWMPXx_nxSlagp3HIB8tkxDKdd7169_cPvFME8f_3qr5fPvmXP5oekKd9IEnHneSfkT3fPCffJyjEli6w66PvrdpSu6VXE5Fn76mhl-OL65TRqaMRoWHRUAvuDN_LaRzX1xFE7QDVoogm0Xa9Dy_IbPrp2-Q87ccnpE5Kvk4VOOfKlaWvpQ3ClXCtMQgAggqZr6vMFyVO5HPeSStcbo0pXCgyVgtVgMg45y_JfrNs_CtCOSInlgaorAJ51lVdWi9LRB0PVZBlQk53bNM_O5QMDdkFcldH7urI3YR8RJbekSC0dfywbG90bynaVc6Y3HADfxGFE8YIFkTgmbGlyQqbkBMUiEbwigarY27MZrXSF1-v9RhyMc7gWhIJedcThSXIyJm-2QCOg3hXA8rDASVYlxsu7-Sud8qpIWWUoEhKwcHf3i3jTqxYa_xygzQIPSch3U2IGujL4PjDlWZxGxG-IWoDR1S9fvAp3pAnDIttcKiSOCT763bjjyBaWtvjaAl_APNEE6U priority: 102 providerName: Scholars Portal |
Title | Cancer immunotherapy by NC410, a LAIR-2 Fc protein blocking human LAIR-collagen interaction |
URI | https://www.proquest.com/docview/2595205778 https://search.proquest.com/docview/2540725010 https://pubmed.ncbi.nlm.nih.gov/PMC8225389 https://doaj.org/article/c9caa1a3ad9d46c4aa42f4f30ab8a06b |
Volume | 10 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Nb9MwFLe2ceGCQIAIjMqgSVxImw87jo9dtWpDazUVJlXiYNmOPSKxdOrHYf897znp1MCNSw_xi1K_Tz_rvd8j5Cw1tsqlL2JuEhEzZ3Ss4aARp9JoiMZa2HDhNpsXl7fs25Ivjwjf98KEon1r6mHz-37Y1L9CbeXDvR3t68RGN7MJBDWwUzk6JsegoAcpenC_AnQylW0vnoBoOXLXtXfDIpMZjtwDt52lBY54PwhEAa__X6_8d6XkQeiZviQvujMjHbf_7RU5cs1r8nOC8lrTGhs8ujaqR2oe6XzC0uQr1fR6fLWIMzq1NIAx1A01ELnwapyGyXwtQVAE0CKKwBHrts3hDbmdXvyYXMbdpITYcp5vYwFxWNqydBU3ntkSPFgGsd4Ln7hKJq4ocfiedZYbZlOjdWF9kWQVEwVIJ8_zt-SkWTXuHaE5giSWGqiMANFVsiqN4yUCjHvpeRmRsz3b1EMLiKEgkUBGq8BoFRgdkXNk6RMJoliHB6v1nepkqay0Wqc61_AVVlimNcs883miTamTwkTkMwpEIU5Fg4Uwd3q32air7ws1hrQrz8ADsYh86Yj8CmRkdddXANtBaKse5WmPEgzJ9pf3cledIW8UZIc8gzOtgI1_elrGN7E4rXGrHdIgyhyHzDYioqcvve33V0C3A5h3p8vv__vND-R5hnU2OE-JnZKT7XrnPsJBaWsGYB5LMSDPzi_mN4tBuG6A3xkrB8Fk_gBQlBhi |
link.rule.ids | 230,315,730,783,787,867,888,2109,12070,21402,24332,27938,27939,31733,31734,33758,33759,43324,43819,53806,53808,74081,74638 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lj9MwELZgOcAFgQARWMCglbgQNg87dk6oVFQtdHtYdqVKHCzbsZdekqWPw_57Zhy3bEDiWk8VZWY839iZ-YaQk9zYpqx9lXKTiZQ5o1MNiUaa10YDGmthw4Xb2aKaXrKvS76MF26bWFa5j4khUDedxTvyU0jTeQHJhZCfrn-lODUKv67GERp3yT3k4ULufLEUhzsWgEcJiNe35QkAzlM3X3n3sSpqnCJzC4gCX_-_UfnvSslb0DN5RB7GnJGOeiM_Jndc-4T8GKO91nSFDR6xjeqGmhu6GLM8-0A1nY9m52lBJ5YGMoZVSw0gF16N0zCZrxcIjgBeRJE4Yt23OTwll5MvF-NpGiclpJbzcpsKwOHaSukabjyzEiJYAVjvhc9cU2eukjh8zzrLDbO50bqyvsqKhokKrFOW5TNy1Hate05oiSSJUoOUEWC6pm6kcVwiwbivPZcJOdmrTV33hBgKDhKoXRW0q4J2E_IZVXoQQRbr8EO3vlJxUyhbW61zXWp4Cqss05oVnvky00bqrDIJeYcGUchT0WIhzJXebTZq9v1cjeDYVRYQgVhC3kch34GNrI59BfA6SG01kDweSMJGssPlvd1V3Mgb9cftEvL2sIz_xOK01nU7lEGWOQ4n24SIgb8MXn-40q5-BjJvSNAAc-oX_3_4G3J_enE2V_PZ4ttL8qDAwhocoMSOydF2vXOvIDPamtfB_X8Dw1AODg |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELegkxAvCASIwAYGTeKF0HzYifOEurJqhVJNhUmTeLBsxx59SbZ-POy_585xywISr_VVUe7O9zs7d78j5DjVps4rV8RcJ2XMrFaxgkQjTiutAI1VafyF27d5cXbBvlzyy1D_tA5llbuY6AN13Rq8Ix9Cms4zSC5KMXShLOL88-TT9U2ME6TwS2sYp3GfHJQMvGpADk5O5-eL_Y0LgKUA_Oua9EqA0aGdLZ39WGQVzpS5A0uevf_fGP133eQdIJo8Jo9CBklHncmfkHu2eUp-jtF6K7rEdo_QVHVL9S2dj1mafKCKzkbTRZzRiaGemmHZUA04hhfl1M_p6wS8W4BPUaSRWHVND8_IxeT0x_gsDnMTYsN5volLQOXKCGFrrh0zAuJZBsjvSpfYukpsIXAUn7GGa2ZSrVRhXJFkNSsLsFWe58_JoGkb-4LQHCkThQIpXYIh66oW2nKBdOOuclxE5HinNnnd0WNIOFagdqXXrvTajcgJqnQvgpzW_od2dSXDFpGmMkqlKlfwFFYYphTLHHN5orRQSaEj8g4NIpG1okH7X6ntei2n3xdyBIewPIN4xCLyPgi5FmxkVOgygNdBoque5GFPEraV6S_v7C7Dtl7LP04Ykbf7Zfwnlqo1tt2iDHLOcTjnRqTs-Uvv9fsrzfKXp_aGdA0QqHr5_4e_IQ_A9-VsOv_6ijzMsMoGpymxQzLYrLb2CNKkjX4d_P83B7cTsQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cancer+immunotherapy+by+NC410%2C+a+LAIR-2+Fc+protein+blocking+human+LAIR-collagen+interaction&rft.jtitle=eLife&rft.au=Ramos%2C+M+Ines+Pascoal&rft.au=Tian%2C+Linjie&rft.au=de+Ruiter%2C+Emma+J&rft.au=Song%2C+Chang&rft.date=2021-06-14&rft.pub=eLife+Science+Publications%2C+Ltd&rft.issn=2050-084X&rft.eissn=2050-084X&rft.volume=10&rft_id=info:doi/10.7554%2FeLife.62927&rft.externalDocID=A666320404 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2050-084X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2050-084X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2050-084X&client=summon |